|CUTLL1 Cells are derived from human T-cell lymphoblastic leukemia (T-ALL) which expresses high levels of NOTCH1. NOTCH1 is an important target in cancer therapies in which inhibition has potential therapeutic significance. The CUTLL1 cells have genetic aberrations with t(7;9)(q34;q34) translocation which increases the NOTCH1 signaling. It is a valuable model for cancer research.|
|Species||Human (H. sapiens)|
|Donor Ethnicity||Donor Info Not Disclosed|
|Donor Age||Donor Info Not Disclosed|
|Donor Disease||T-cell lymphoma|
|Seeding Density||Thaw entire contents into an appropriate T25 flask as specified in the Propagation instructions.|
|Applications||For Research Use Only|
|Unit quantity||1×106 cells/1.0ml|
|Cell Type||Tumor Cells|
|Propagation Requirements||Use of PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) is required for cell adhesion to the culture vessels.
The base medium for this cell line is Prigrow II medium available at abm, Cat. No. TM002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (TM999) to final concentration of 20% and Penicillin/Streptomycin Solution (G255) at a final concentration of 1%. Carbon dioxide (CO2): 5%, Temperature: 37.0°C.
1. For for-profit organizations and corporations, please contact firstname.lastname@example.org for pricing of this item.
2. Sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchasing individual/institution for each order. If you have any questions regarding this, please contact us at email@example.com.
3. All test parameters provided in the CoA are conducted using abm‘s standardized culture system and procedures. The stated values may vary under the end-user’s culture conditions. Please verify that the product is suitable for your studies by referencing published papers or ordering RNA (0.5 μg, Cat.# C207, $450.00) or cell lysate (100 μg, Cat.# C206, $600.00) to perform preliminary experiments, or alternatively use our Gene Expression Assay Service (Cat# C138). All sales are final.
4. We recommend live cell shipments for ease of cell transfer and this option can be requested at the time of ordering. Please note that the end-user will need to evaluate the feasibility of live cell shipment by taking into account the final destination’s temperature variation and its geographical location. In addition, we thoroughly test our cell lines for freeze-thaw recovery. If frozen cells were received and not recovered in your lab under the exact, specified conditions (using recommended culture vessel, media, additional supplements, and atmospheric conditions), a live cell replacement is possible at a cost (plus shipping).
5. All of abm‘s cell biology products are for research use ONLY and NOT for therapeutic/diagnostic applications. abm is not liable for any repercussions arising from the use of its cell biology product(s) in therapeutic/diagnostic application(s). Please contact a technical service representative for more information.
6. abm makes no warranties or representations as to the accuracy of the information on this site. Citations from literature and provided for informational purposes only. abm does not warrant that such information has been shown to be accurate.
7. abm warrants that cell lines shall be viable upon initiation of culture for a period of thirty (30) days after shipment and that they shall meet the specifications on the applicable abm Material Product Information sheet, certificate of analysis, and/or catalog description. Such thirty (30) day period is referred to herein as the “Warranty Period.”
|Caution||For Research Use Only|
There are no FAQs for this product yet!
- Hitora, T., Yamamoto, T., Akisue, T., Marui, T., Nakatani, T., Kawamoto, T., … & Kurosaka, M. (2005). Establishment and characterization of a KIT‐positive and stem cell factor‐producing cell line, KTHOS, derived from human osteosarcoma. Pathology international, 55(2), 41-47.
- DeComas, A. M., Penfornis, P., Harris, M. R., Meyer, M. S., & Pochampally, R. R. (2010). Derivation and characterization of an extra-axial chordoma cell line (EACH-1) from a scapular tumor. The Journal of bone and joint surgery. American volume, 92(5), 1231–1240. https://doi.org/10.2106/JBJS.I.00594